Pain ‐ 24hrs (Single dose) · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Pain ‐ 1‐2 weeks · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Withdrawals due to adverse events · patients with pain management in rheumatoid arthritis
It is very uncertain whether muscle relaxant changes withdrawal due to Adverse Events compared with control (very low certainty).
1 finding from 1 review
Total Number of Adverse Events ‐ only studies >24hrs duration · patients with pain management in rheumatoid arthritis
It is very uncertain whether muscle relaxant changes total Number of Adverse Events ‐ only studies >24hrs duration compared with control (very low certainty).
1 finding from 1 review
Total Number of Adverse Events ‐ single dose studies · patients with pain management in rheumatoid arthritis
It is very uncertain whether muscle relaxant changes total Number of Adverse Events ‐ single dose studies compared with control (very low certainty).
1 finding from 1 review
CNS adverse events · patients with pain management in rheumatoid arthritis
It is very uncertain whether muscle relaxant changes CNS adverse events compared with control (very low certainty).
1 finding from 1 review
Jaw pain (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral cyclobenzaprine (muscle relaxant) showed no clear difference in jaw pain (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
Adverse events (reported; mild, no withdrawals) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
1 finding from 1 review
Herman et al 2002 (cyclobenzaprine) reported adverse effects. Per the review's Adverse effects of interventions section: 'All but one study (Lobo et al 2004) reported adverse effects. Most of the reported adverse…
1 study · 41 participants
GRADE not reported